New Results

Safety and Potency of COVIran Barekat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study

Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ebrahim Azimi, Nabbi Emamipour, Hamidreza Jamshidi, Mohammadreza Hosseinpour, Mohammad Taqavian, Hasan Jalili
doi: https://doi.org/10.1101/2021.06.10.447951

Article usage

Article usage: June 2021 to September 2023

AbstractFullPdf
Jun 202120781148011302
Jul 202116742714127
Aug 202127155169344
Sep 202117413655242
Oct 202112903442723
Nov 202138382442
Dec 202143497599
Jan 202224039567
Feb 202225644402
Mar 202221321386
Apr 202222221425
May 202213910244
Jun 202211611276
Jul 202210512231
Aug 2022111242195
Sep 202210111185
Oct 20228017145
Nov 202211126131
Dec 20225922106
Jan 20237212107
Feb 2023439111
Mar 2023655105
Apr 202359594
May 202338372
Jun 202336178
Jul 2023561392
Aug 202338369
Sep 202331573
Back to top
Posted June 10, 2021.
Download PDF
Email
Safety and Potency of COVIran Barekat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study
Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ebrahim Azimi, Nabbi Emamipour, Hamidreza Jamshidi, Mohammadreza Hosseinpour, Mohammad Taqavian, Hasan Jalili
bioRxiv 2021.06.10.447951; doi: https://doi.org/10.1101/2021.06.10.447951
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area